Kemp EH, Gavalas NG, Gawkrodger DJ, et al. Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo[J]. Autoimmun Rev, 2007, 6(3): 138⁃142. DOI: 10.1016/j.autrev. 2006.09.010.
[2]
Baharav E, Merimski O, Shoenfeld Y, et al. Tyrosinase as an autoantigen in patients with vitiligo[J]. Clin Exp Immunol, 1996, 105(1): 84⁃88. DOI: 10.1046/j.1365⁃2249.1996.d01⁃727.x.
[3]
Kemp EH, Waterman EA, Gawkrodger DJ, et al. Autoantibodies to tyrosinase⁃related protein⁃1 detected in the sera of vitiligo patients using a quantitative radiobinding assay[J]. Br J Dermatol, 1998, 139(5): 798⁃805. DOI: 10.1046/j.1365⁃2133.1998.02503.x.
[4]
Kemp EH, Gawkrodger DJ, MacNeil S, et al. Detection of tyrosinase autoantibodies in patients with vitiligo using 35S⁃labeled recombinant human tyrosinase in a radioimmunoassay[J]. J Invest Dermatol, 1997, 109(1): 69⁃73. DOI: 10.1111/1523⁃1747.ep12276556.
del Marmol V, Beermann F. Tyrosinase and related proteins in mammalian pigmentation[J]. FEBS Lett, 1996, 381(3): 165⁃168. DOI: 10.1016/0014⁃5793(96)00109⁃3.
[8]
Yaghoobi R, Omidian M, Bagherani N. Vitiligo: a review of the published work[J]. J Dermatol, 2011, 38(5): 419⁃431. DOI: 10.1111/j.1346⁃8138.2010.01139.x.
[9]
Song YH, Connor E, Li YX, et al. The role of tyrosinase in autoimmune vitiligo[J]. Lancet, 1994, 344(8929): 1049⁃1052. DOI: 10.1016/S0140⁃6736(94)91709⁃4.